🇺🇸 FDA
Patent

US 6613792

Treatment of premenstrual syndrome and menopause

expired A61KA61K31/4035A61K31/407

Quick answer

US patent 6613792 (Treatment of premenstrual syndrome and menopause) held by Designed Nutritional Products, Inc. expires Mon Aug 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Designed Nutritional Products, Inc.
Grant date
Tue Sep 02 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/4035, A61K31/407, A61K31/7056